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bstract
The S100 family member S100A9 and its heterodimeric partner, S100A8, are cytosolic Ca2+ binding proteins abundantly expressed
n neutrophils. To understand the role of this EF-hand-containing complex in Ca2+ signalling, neutrophils from S100A9 null mice were
nvestigated. There was no role for the complex in buffering acute cytosolic Ca2+ elevations. However, Ca2+ responses to inflammatory agents
uch as chemokines MIP-2 and KC and other agonists are altered. For S100A9 null neutrophils, signalling at the level of G proteins is normal,
s is release of Ca2+ from the IP3 receptor-gated intracellular stores. However MIP-2 and FMLP signalling in S100A9 null neutrophils was
ess susceptible than wildtype to PLC inhibition, revealing dis-regulation of the signalling pathway at this level. Downstream of PLC, there
as reduced intracellular Ca2+ release induced by sub-maximal levels of chemokines. Conversely the response to FMLP was uncompromised,
emonstrating different regulation compared to MIP-2 stimulation. Study of the activity of PLC product DAG revealed that chemokine-induced
ignalling was susceptible to inhibition by elevated DAG with S100A9 null cells showing enhanced inhibition by DAG. This study defines a
esion in S100A9 null neutrophils associated with inflammatory agonist-induced IP3-mediated Ca2+ release that is manifested at the level of
LC.
2006 Elsevier Ltd. All rights reserved.
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. Introduction
S100A8 and S100A9 are low molecular weight Ca2+ bind-
ng proteins of the EF-hand type that are part of a family
f approximately 19 members [1–4]. Uncharacteristically
or S100 proteins, S100A8/9 exists as a hetero-, rather than
omodimer [5,6]. These members of the S100 family are
Abbreviations: 2-APB, 2-aminoethyldiphenyl borate; AM, ace-
oxymethyl ester; BIM, bisindolylmaleimide; CaBP, calcium binding pro-
ein; DAG, diacylglycerol; ER, endosplasmic reticulum; FMLP, N-formyl-
ethionyl-leucyl-phenylalanine; HBSS, Hanks buffered saline solution; IP3,
nositol-1,4,5-triphosphate; mAb, monoclonal antibody; MIP, macrophage
nflammatory protein; OAG, 1-oleoyl-2-acyl-sn-glycerol; PAF, platelet acti-
ating factor; PKC, protein kinase C; PLC, phospholipase C; PTX, pertussis
oxin; SOCE, store operated calcium entry
∗ Corresponding author. Tel.: +44 20 7269 3255; fax: +44 20 7269 3093.
E-mail address: Nancy.Hogg@cancer.org.uk (N. Hogg).
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oi:10.1016/j.ceca.2006.05.004rimarily expressed by neutrophils and monocytes [4]. In
uman neutrophils, the heterodimer constitutes an abundant
0% of the cytosolic protein [5] and, similarly, in murine
eutrophils, the S100A9 protein alone represents 10–20% of
ytosolic protein [7].
In resting neutrophils the S100A8/9 complex is present
n the cytosol but treatment with stimuli such as zymosan
ause the complex to move to the membrane [8,9] possi-
ly into detergent insoluble lipid rafts [10]. Alternatively, in
uman monocytes, the Ca2+ ionophore, ionomycin, causes
he heterodimer to translocate from the cytosol to the
ytoskeletal and vimentin-containing structures [11,12]. A
raction of S100A8/9 becomes phosphorylated following
xposure to agonists [13] and, in monocytes, there is pref-
rential translocation of phosphorylated S100A8/9 to the
embrane and cytoskeletal fraction [14]. An association of
100A8/9 with the microtubule system and secretion of the
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omplex in a tubulin-dependent manner has been reported
15].
S100 proteins are unusual in having both intracellular and
xtracellular roles assigned to them. Neutrophil chemoattrac-
ant activity has been attributed to murine S100A8 [16] and
o human S100A8 and S100A9 proteins [17], although these
ndings have been questioned by others [18]. The association
f S100A8/9 with the vascular cell surface in proximity to
xtravasating leukocytes is suggestive of involvement in the
rocess of leukocyte trafficking [1]. S100A8/9 binds to cell
urface heparan-sulphate glycosaminoglycans on endothelial
ells, thereby being appropriately positioned to affect leuko-
yte recruitment or another extracellular role [19]. A car-
oxylated N-glycan motif present on the surface of endothe-
ial cells also binds S100A8/9 and a mAb specific for this
-glycan reduced the recruitment of neutrophils in vivo pro-
iding further suggestive evidence of a role for these proteins
n leukocyte trafficking [20,21]. Treatment of endothelial
ells with recombinant S100A8/9 has also been reported to
ause a decrease in monolayer integrity and expression of
ro-inflammatory mediators [22].
The initial characterization of the S100A9 null mice indi-
ated that the protein is dispensable for life span, morphologi-
al features and many functions of neutrophils and monocytes
23,24]. The most obvious difference between the S100A9
ull and wildtype neutrophils is the absence of S100A8
mplying that it is unstable without its S100A9 partner as
uggested previously [25]. Although many neutrophil func-
ions appear unaffected in the S100A9 null mice, the S100A9
ull neutrophils did exhibit reduced Ca2+ signalling to sub-
aximal levels of stimulation to the chemokine MIP-2 [23].
Proteins of the S100 family have been considered to be
a2+ buffering proteins but may act as Ca2+ sensors. Upon
a2+ binding, S100 dimers undergo a conformational change
xposing a hydrophobic interaction surface deemed to medi-
te their interaction with target proteins (reviewed in [26]).
ther S100 proteins have been highlighted as having a role
n Ca2+ homeostasis. S100A1 null mice have a lesion in the
a2+ response to-adrenergic stimulation in cardiomyocytes
nd show lack of compensation for an increased cardiac
orkload in a model of acute hemodynamic stress [27].
ver-expression of S100A1 causes increased Ca2+ loading of
he sarcoplasmic reticulum in cardiomyocytes [28]. Finally
100B null mice show enhanced Ca2+ transients in response
o caffeine in astrocyte cell cultures [29].
Neutrophil functions can be regulated by Ca2+ and
hemoattractants represent well-defined stimuli of Ca2+ sig-
alling in neutrophils (reviewed in [30,31]). However, neither
he details of chemoattractant-induced signalling pathway(s)
eading to Ca2+ increases nor the functional outcomes are
ully defined [32,33]. In this study, the basic Ca2+ homeosta-
is and chemoattractant-induced Ca2+ signals in neutrophils
re examined in an effort to understand the Ca2+ signalling
esion in the S100A9 null neutrophils. We find that S100A8/9
oes not act as a major Ca2+ buffer, but Ca2+ signalling is
is-regulated at the level of PLC in response to chemoattrac-
2
im 41 (2007) 107–121
ants. For a number of chemokines and other chemoattactants,
ut not FMLP, this dis-regulation reveals a downstream role
or PLC product, DAG, which has a suppressive effect at
nhanced levels on Ca2+ release from IP3 receptor-regulated
a2+ stores.
. Experimental
.1. Antibodies and other reagents
Rabbit polyclonal anti-PLC2 (Santa Cruz Biotech.),
nti-PLC3 (Cell Signalling Tech.), and mouse anti-IP3R
Chemicon Intl.) were used. The rabbit polyclonal anti-
XCR2 antibody was a kind gift from R.M. Strieter
UCLA). Goat anti-rabbit immunoglobulin-horseradish per-
xidase conjugate and goat anti-mouse immunoglobulin-
orseradish peroxidase conjugate were both from Dako Ltd.
lexa 488-conjugated donkey anti-goat polyclonal and Alexa
33-conjugated goat anti-rat were obtained from Invitro-
en/Molecular Probes. MAb 7/4 was obtained from Caltag
edsystems and anti-Mac-1 and Ly-6G mAbs were obtained
rom BD Biosciences/Pharmingen.
The following stimulants were used: FMLP (Sigma),
onomycin (Calbiochem), thapsigargin (Calbiochem),
hemokines KC, MIP-1, and MIP-2 (all Peprotech EC),
AF, C5a and G protein activator ALF4− (all Sigma).
he following inhibitors were used: IP3 receptor inhibitor
-aminoethoxydiphenyl borate (2-APB), protein kinase C
nhibitors (BIM and Calphostin C), DAG kinase inhibitor II
R59949), DAG mimetic olelylacylglycerol (OAG), pertus-
is toxin (PTX), DAG lipase inhibitor (RHC 80267), PLC
nhibitor (U73122) and control compound (U73343) (all
albiochem). All reagents were titrated and used at maximal
oncentrations with due consideration of neutrophil viability.
A membrane-permeant derivative of IP3, IP3-AM, was
sed to stimulate the IP3 receptors directly. IP3-AM is a form
f IP3 in which the phosphate groups are protected with the
ipophilic butyryloxymethyl groups. These groups allow the
ster to diffuse across the cell membrane but once in the
ell are removed by esterases revealing IP3. The IP3-AM
ster was synthesised in a manner similar to that reported for
tdIns(4,5)P2 [34] combined with the approach reported by
sien and co-workers [35].
.2. Animal husbandry
S100A9 null mice were generated as published previ-
usly [23]. Wildtype and S100A9 null mice from the same
ackcross generation (7–9) were used until backcross gener-
tion 10 when in-house C57BL/6J control mice were used.
ice were maintained in specific pathogen-free conditions
n accordance with UK Home Office guidelines..3. Murine bone marrow leukocytes
Murine bone marrow leukocytes were harvested by flush-
ng both femurs and tibiae with Hank’s buffered salt solution
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HBSS: 0.4 g/l KCl, 0.06 g/l KH2PO4, 8 g/l NaCl, 0.9 g/l
a2HPO4, 0.35 g/l NaHCO3, 1 g/l d-glucose) (Gibco) con-
aining 0.2% BSA (Sigma) using a needle and 2.5 ml syringe.
ell clumps were dispersed by gentle agitation with a plastic
astette prior to passage through a 70M cell strainer (Fal-
on). The cells were pelleted by centrifugation at 500 × g
or 5 min before resuspension in 1 ml hypotonic red blood
ell lysis solution (0.144 M NH4Cl/0.017 M Tris–HCl, pH
.2). Red blood cells were lysed at room temperature for
min, then washed and resuspended in the relevant assay
uffer.
.4. Chemotaxis
Transwell (Corning) plates with a 3m pore and 6.5 mm
iameter insert were pre-incubated with chemotaxis buffer
HBSS containing 20 mM HEPES, 1 mM Ca2+, 1 mM Mg2+,
0M Zn2+ and 0.1% BSA) at 37 ◦C for 1 h. About
00l chemotaxis buffer containing various chemoattrac-
ant stimuli was placed in the plate wells. The Transwell
nsert was replaced and 5 × 106/ml bone marrow leuko-
ytes in 100l added. The plates were incubated for 2–4 h
t 37 ◦C prior to removal of the insert and collection
f the buffer from the lower chamber for analysis. The
ower chambers were washed with ice-cold PBS/EDTA
5 mM) twice and the additional recovered cells added
o the buffer sample. The harvested cells were pelleted
nd stained in FACSwash as previously [36] to identify
he neutrophils prior to absolute cell counting by flow
ytometry.
.5. FACS staining of leukocyte suspensions
2 × 105 leukocytes were incubated in HBSS/0.2% BSA
ontaining saturating concentrations of CXCR2 antibody
1:50) on ice in the dark for 15 min. The leukocytes were
ashed and the incubation procedure repeated with Alexa
88-conjugated donkey anti-goat antibody (1:100) followed
y a directly conjugated myeloid cell detection cocktail
mAbs 7/4-PE and Ly-6G-FITC, 1:100 and 1:200, respec-
ively) as previously described [36]. Analysis of cell surface
eceptor expression was carried out using a FACS-Calibur
Becton Dickinson).
For Mac-1 (CD11b/CD18) up-regulation experiments,
one marrow leukocytes were stimulated with chemokines
s indicated for 30 min at 37 ◦C prior to surface labelling.
ac-1 was detected using anti-Mac-1 mAb (1:100) followed
y Alexa 633-conjugated goat anti-rat antibody (1:100)
nd the directly conjugated myeloid cell detection cocktail
s above.
.6. Measurement of intracellular calcium concentrationThe use of a ratiometric Ca2+ indicator avoids problems
f differential dye loading, as the change in Ca2+ concentra-
ion within each cell is measured as a ratio of the dye states,
t
a
c
(m 41 (2007) 107–121 109
hus eliminating any differences in dye loading between
amples. Bone marrow leukocytes were prepared in Flux
uffer (HBSS, as before, supplemented with 1 mM Ca2+ and
.5% BSA) and resuspended at 1 × 107/ml in 2.5 mM Indo-
AM/2.5% pluronic acid (both Molecular Probes). The cell
uspension was incubated at 30 ◦C for 1 h prior to wash-
ng in Flux buffer (30 ◦C). The cells were resuspended at
× 107/ml in Flux buffer containing mAbs 7/4-PE and Ly-
G/Gr-1-FITC for 15 min at 30 ◦C. Cells were washed one
nal time and resuspended at 5 × 106/ml and maintained
t 30 ◦C prior to use. For inhibitor studies requiring pre-
ncubation, aliquots of cells were separated into tubes with
he inhibitor indicated. Fluorescence was monitored using
BD LSR flow cytometer (FL-4 530/30 nm BF filter, FL5
24/44 filter, 510LP filter; BD Biosciences). Samples were
ead at a flow rate of 2000–3000 events/s and stimulants
ere added from 100× stock solutions at the indicated time
oints. Data was analysed using FlowJo software (TreeStar
nc.). Results are represented as the median Indo-1 ratio for
00–700 neutrophils/s.
.7. Western blotting
Cells were suspended at 5 × 107/ml in ice-cold lysis buffer
50 mM Tris pH 8.0 containing 1% Triton X-100 (Sigma),
mM EDTA, 50 mM NaCl, 20g/ml PMSF (Sigma),
g/ml aprotinin (Sigma)) and incubated for 30 min on ice
ith intermittent disruption with a 25G needle. The solu-
ion was then centrifuged in a microfuge to remove insoluble
aterial and the supernatant decanted and subjected to 6%
olyacrylamide gel electrophoresis followed by transfer to
itrocellulose.
Western blotting was performed with rabbit anti-PLC2
1:100, Santa Cruz Biotech.), anti-PLC3 (1:100, Cell Sig-
alling Tech.) and mouse anti-IP3R (1:200, Chemicon Intl.)
ntibodies followed by goat anti-rabbit immunoglobulin-
orseradish peroxidase conjugate (1:500) or goat anti-mouse
mmunoglobulin-horseradish peroxidase (1:500) conjugate
both Dako Ltd.).
. Results
.1. Basic calcium signalling parameters in S100A9 null
ice
To assess whether the deletion of S100A8/9 had an impact
n the Ca2+ signalling potential of the neutrophils, we first
nvestigated Ca2+ homeostasis. Treatment of the S100A9 null
nd wildtype neutrophils with the Ca2+ ionophore ionomycin,
hich causes Ca2+ influx across the plasma membrane, or
hapsigargin, which is an inhibitor of the Ca2+ ATPase on
he Ca2+ stores within the endoplasmic reticulum, caused
n identical sustained or transient rise respectively in intra-
ellular Ca2+ in both wildtype and S100A9 null neutrophils
Fig. 1A and B). That the magnitude of the response is
110 E. McNeill et al. / Cell Calcium 41 (2007) 107–121
Fig. 1. Normal calcium homeostasis in S100A9 null neutrophils. Bone marrow leukocytes were loaded with Indo-1 and neutrophils were identified by labelling
with mAbs 7/4 and Ly-6G. Intracellular Ca2+ concentration was monitored by flow cytometry and expressed as the arbitrary ratio of the Indo-1 fluorescence
at 424 and 530 nm. Stimulants were applied at the indicated times (). The median response of neutrophil Indo-1 ratio of ≈500–700 events is plotted every
second. The response to stimulation: (A) with 1M ionomycin in the presence of extracellular 1 mM Ca2+; (B) with 5M thapsigargin in the presence and
absence of 1 mM extracellular Ca2+ with absence generated by chelation with 4 mM EGTA; (C) Store Operated Ca2+ Entry is examined by treatment of the
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ceutrophils with 5M thapsigargin in the absence of extracellular Ca2+, pr
ndependent experiments.
quivalent in both cell types implies that S100A8/9 is not
cting as a major cellular Ca2+ buffer. When the cells were
reated with thapsigargin in the presence of extracellular
a2+, there was a biphasic increase in intracellular Ca2+
Fig. 1B). The second phase of Ca2+ elevation is caused
y opening of Ca2+ channels on the cell surface to allow
e-filling of the emptying stores, termed Store Operated Cal-
ium Entry (SOCE). SOCE can be assessed by treatment of
he cells with thapsigargin in Ca2+ free buffer to fully empty
he Ca2+ stores, then addition of Ca2+ to the buffer and obser-
ation of the profiles of the response. SOCE in the wildtype
nd S100A9 null cells is identical over a range of extracellular
a2+ concentrations (Fig. 1C). No up-regulation of other pro-
eins to compensate for the loss of the S100A8/9 heterodimer
as been observed in the S100A9 null mice by 2D gel anal-
sis of bone marrow cells [23]. In addition RT-PCR studies
f the expression of other S100 proteins previously detected
n leukocytes (S100A1, S100A4) revealed no compensatory
ncrease in these family members (Supplementary Fig. 1).
herefore, there is no gross defect in Ca2+ homeostasis in the
nockout cells. This function must be regulated by a means
ot involving S100A8/9.
t
w
o
cdd-back of Ca2+ at 0.5–2 mM. All data are representative of three or more
.2. Defective calcium signalling to a range of, but not
ll, chemoattractants
To test the ability of the neutrophils to mount a Ca2+
esponse to physiological stimuli, we examined the response
o various chemoattractants, extending the previous observa-
ion that the S100A9 null neutrophils exhibited a defect in
a2+ signalling to the chemokine MIP-2 [23]. The S100A9
ull and wildtype neutrophils were stimulated with a titra-
ion of the CXC chemokine, MIP-2, in the presence of
xtracellular Ca2+. At higher levels of chemokine (10 ng/ml)
here was no difference in the magnitude or duration of
he response, but at lower levels of stimulation (1 and
.3 ng/ml), there was a decreased Ca2+ flux response in the
100A9 null neutrophils compared with the wildtype cells
Fig. 2A). A similar defect was observed upon stimulation
f wildtype and knockout neutrophils with a second CXC
hemokine KC, CC chemokine MIP-1 and the chemoat-
ractants PAF and C5a (Fig. 2B). However, when neutrophils
ere exposed to FMLP, no defect in Ca2+ flux response was
bserved at any concentration of stimulus in the knockout
ells (Fig. 2C). This data suggests that while the S100A9
E. McNeill et al. / Cell Calcium 41 (2007) 107–121 111
Fig. 2. Reduced calcium response to MIP-2 and other stimulants, but not to FMLP. (A) The Ca2+ response of neutrophils to the chemokine MIP-2 assessed as
d 2+ s KC a 2+
n depend
n
d
s
a
a
r
n
3
cescribed in Fig. 1. (B) The Ca response of neutrophils to the chemokine
eutrophils to the chemoattractant FMLP. Data are representative of three in
ull neutrophils are compromised in their ability to pro-
uce a Ca2+ flux in response to a range of chemoattractant
timuli, this lesion is not generalised, but a problem with
specific signalling pathway that is used by some but not
ll chemoattractants. Alternatively a lesion in the signalling
esponse to FMLP may be compensated for in S100A9 null
eutrophils.
w
t
und MIP-1 and chemoattractants, C5a and PAF. (C) The Ca response of
ent experiments.
.3. The defect in calcium flux is not seen in other
hemoattractant-induced neutrophil responsesWhen neutrophils are stimulated with chemoattractant, as
ell as activation of a calcium flux, the cells are stimulated
o chemotax towards the source of the stimulus and also to
p-regulate the cell surface integrin Mac-1 (CD11b/CD18),
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marker of cell activation. To examine further whether
he observed defect in calcium signalling is a generalised
ecrease in responsiveness to chemoattractant, the abil-
ty of wildtype and S100A9 null neutrophils to perform
hese functions in response to MIP-2, KC and FMLP was
xamined.
No significant difference in in vitro chemotaxis in response
o MIP-2, KC or FMLP was observed either at maximal
r lower concentrations (correlating with the decreased cal-
ium response in the S100A9 null mice) when wildtype and
100A9 null cells were compared (Fig. 3A). Similarly, when
he levels of Mac-1 were evaluated following chemoattrac-
ant stimulation at maximal and sub-maximal levels of MIP-2
nd FMLP, there was no reproducible difference in the ability
f the S100A9 null and wildtype neutrophils to be activated
Fig. 3B). These data indicate that there is not a generalised
hift in the responsiveness of the S100A9 null neutrophils to
hemokine stimulation.
.4. The defect in calcium flux in the S100A9 null
eutrophils is in intracellular calcium release
To ascertain the source of Ca2+ for the response to the
hemoattractants, neutrophils were stimulated in the presence
r absence of extracellular Ca2+. When the neutrophils were
timulated with 20 ng/ml MIP-2, the response had a similar
agnitude, but decreased duration in the absence compared
o the presence of extracellular Ca2+ (Fig. 4). At a lower dose
f MIP-2 (1 ng/ml), the response had a similar magnitude and
uration both in the presence and absence of extracellular
a2+. The majority of the Ca2+ contributing to this response
herefore derives from the intracellular Ca2+ stores, with a
inor component of extracellular Ca2+ entry contributing at
igh levels of chemokine. As the lesion in Ca2+ signalling is
vident in both situations, it must be localised to the mech-
nisms of intracellular Ca2+ release. The response to FMLP
elies on both intracellular and extracellular Ca2+, but the
esponses of S100A9 wildtype and null neutrophils are simi-
ar (Fig. 4). When the response to C5a was studied in a similar
anner, the lesion was again found to be in intracellular Ca2+
elease (data not shown). Thus, enhanced extracellular Ca2+
ntry is not compensating for the intracellular Ca2+ release
eficiency seen in the responses of the S100A9 null cells
o the chemokines. As we were investigating primary neu-
rophils, to determine the characteristics of the compromised
ntracellular Ca2+ release pathway in S100A9 null mice, a
easible approach was to undertake a pharmacological study
o compare the effect of different agents on the responses to
he chemoattractants.
.5. The MIP-2- and FMLP-induced calcium fluxes
ccur via G protein coupled pathway(s)This shift in the dose–response to chemoattractant could
heoretically be explained by a lower expression of the recep-
or on the cell surface. However, expression of the CXCR2
g
n
M
wm 41 (2007) 107–121
eceptor that binds CXC chemokines, MIP-2 and KC, was
t a similar level on both the wildtype and S100A9 null
eutrophils (Fig. 5A). As MIP-1, PAF and C5a all bind
o distinct membrane receptors, it seemed unlikely that the
esion in Ca2+ signalling is at this level.
To test whether the Ca2+ flux responses occur normally
ia a G protein coupled receptor pathway, the neutrophils
ere pre-incubated with pertussis toxin (PTX). The magni-
ude of the response to both MIP-2 and FMLP was reduced
n the presence of PTX in both wildtype and S100A9 null
ells (Fig. 5B). To confirm that the Gi protein coupled Ca2+
elease pathways were broadly normal in these cells, they
ere treated with AlF4− that non-specifically activates G
roteins and again the response was similar in wildtype and
100A9 null cells (Fig. 5C).
.6. MIP-2- and FMLP-induced calcium fluxes are
ifferentially inhibited by PLC inhibitor U73122 in
ildtype and S100A9 null neutrophils
The findings so far indicate that, in S100A9 neutrophils,
he chemokine-induced Ca2+ flux operates normally at the
evel of the chemokine receptor. To ask whether the S100A9
ull neutrophil lesion is due to an abnormality elsewhere in
he signalling pathway, we next focussed on phospholipase C
PLC), which is activated by heterotrimeric G proteins. At
0M U73122, the cell-permeable PLC inhibitor U73122
nhibited both MIP-2- and FMLP-induced Ca2+ fluxes indi-
ating that PLC has a role in both pathways (Fig. 6A).
owever, the S100A9 null cells were less inhibited than
he wildtype neutrophils at 1M U73122. The inactive PLC
nalogue U73343 had no effect on either MIP-2 or FMLP
ignalling in wildtype or S100A9 null cells (Supplementary
ig. 2). PLC2 and PLC3 are the PLC isoforms transduc-
ng chemokine-induced Ca2+ flux in murine neutrophils [37]
nd Western blotting revealed that their levels were similar in
ildtype and S100A9 null neutrophils (Fig. 6B). Attempts to
ssess the function of PLC by measuring IP3 production in
esponse to agonist stimulation using commercially available
eagents were unsuccessful, with IP3 levels being below the
imits of detection using the maximum feasible number of
eutrophils.
.7. An IP3-mediated calcium release pathway is
ompromised in S100A9 null neutrophils
The IP3 receptor is a ligand-operated ion-channel
xpressed on the Ca2+ stores in the endoplasmic reticulum,
nd the IP3-mediated Ca2+ release pathway is one of the
ajor Ca2+ release pathways in non-excitable cells. An
nhibitor of IP3R activity, 2-aminoethoxydiphenyl borate
2-APB) was examined at a dose of chemoattractant that
ave equivalent Ca2+ flux responses in wildtype and S100A9
ull neutrophils. 2-APB caused a large decrease in the
IP-2-induced Ca2+ flux response in the S100A9 null cells
ith only minimal effects on the wildtype cells (Fig. 7A). In
E. McNeill et al. / Cell Calcium 41 (2007) 107–121 113
Fig. 3. Neutrophil chemotaxis and Mac-1 (CD11b/CD18) up-regulation in response to chemoattractants. (A) Migration of bone marrow neutrophils in response
t a Trans
p ts. (B)
w ll surfac
c e and re
c
n
M
fl
ro MIP-2, FMLP and KC, at the concentrations shown, was evaluated using
er genotype ± S.D. and are representative of three independent experimen
ith MIP-2 and FMLP at the concentrations shown for 30 mins at 37 ◦C. Ce
ytometry. Data shown are for pooled samples from three mice per genotyp
ontrast, there was no difference in the response of S100A9
ull and wildtype neutrophils to FMLP. At lower doses of
IP-2 and FMLP, 2-APB completely inhibited the Ca2+
ux indicating that both stimulants are dependent on the IP3
eceptor for Ca2+ release.
w
W
p
nwell model of chemotaxis. Data are expressed as the mean of three samples
Bone marrow cells from S100A9 null and wildtype mice were stimulated
e Mac-1 expression on the neutrophils was examined by multi-colour flow
presentative of three independent experiments.
To check whether the possible lesion in the IP3 path-
ay could be due to differential expression of this receptor,
estern blotting of a 98% pure neutrophil population was
erformed using a pan-IP3 receptor antibody. This revealed
o gross difference in IP3 receptor expression (Fig. 7B). To
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esistant to inhibition by U73122. A further possibility is that
100A8/9 may interact with PLC to modulate IP3 produc-
ion. Due to limitations of the antibodies available, in our
ands it was not possible to immunoprecipitate PLC2 or 3
rom murine neutrophils preventing further assessment of any
irect interaction of S100A8/9. Complex formation between
LC and another Ca2+ binding protein, calmodulin (CaM)
as been demonstrated. PLC3/CaM positively affects mus-
arinic receptor stimulation of inositol phospholipid hydrol-
sis [47] and PLC1 interacts with CaM plus/minus the
TPase Ral1 to regulate the activity of this PLC [48].
IP3 is produced by the action of PLC in response to the
hemoattractants and it is the mediator triggering the IP3R on
he Ca2+ stores. An assessment of IP3 levels following stimu-
ation would be an appropriate measure of the activity of the
LC isoforms. Rigorous attempts to measure neutrophil IP3
evels using purified cell populations were unfortunately not
uccessful. We concluded that IP3 levels in stimulated mouse
eutrophils were below the limits of the means of detection
urrently available to us. At the level of the Ca2+ stores,
everal studies have demonstrated the influence of Ca2+ bind-
ng proteins with ligand-gated Ca2+ release channels. The
se of the IP3 ester, which directly stimulates IP3R activity
38] revealed no effect of the absence of S100A8/9 on Ca2+
elease from the internal stores implying a lack of modulating
ffect of S100A8/9 on this receptor. Furthermore, attempts to
o-immunoprecipitate S100A8/9 and the IP3 receptor using
eneral and isotype specific antibodies were unsuccessful
data not shown).
There are several studies documenting Ca2+ binding pro-
ein ligands for the IP3 receptor that can either enhance or
nhibit its activity. CaM in its Ca2+-unbound apo-CaM form
nhibits IP3 binding to the IP3 receptor. In its Ca2+-bound
tate, Ca-CaM facilitates the Ca2+-mediated inactivation of
he receptor (reviewed in [49,50]). More recent studies have
ighlighted a modulatory effect of CaBP1 on IP3 receptor
ctivation, with demonstrations of contrasting positive and
egative roles for this protein on IP3 receptor activity. In one
odel, Ca2+ binding protein-1 (CaBP1) was shown to interact
irectly in a Ca2+-dependent manner with the IP3 receptor by
o-immunoprecipitation and by the positive effect of CaBP1
n IP3 receptor opening as measured by individual channel
atch clamping [51]. Alternatively, two studies have iden-
ified an inhibitory role for CaBP1 in that over-expressed
aBP1 has a negative effect on IP3 receptor activity follow-
ng direct stimulation with IP3-ester [52] and also in response
o purinergic receptor stimulation by physiological agonists
53]. Interestingly the S100 family member S100A1 inter-
cts with a second class of Ca2+ release channels, which
re the ryanodine receptor types I and II [28,54]. In the car-
iomyocytes of S100A1-overexpressing transgenic mice, the
arcoplasmic reticulum, a major Ca2+ storage structure in
xcitable cells, has increased Ca2+ content [28]. In light of
his data, it was of relevance that the lack of S100A8/9 had
o effect on Ca2+ stores, further indicating that the lesion is
ot at this level.
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In the S100A9 null neutrophils the signalling by FMLP
nd MIP-2 leading to Ca2+ flux is via PLC and the IP3 recep-
or, as both are sensitive to PLC inhibitor, U73122, and IP3
eceptor inhibitor, 2-APB. In spite of an abnormal response at
he level of PLC, no lesion in FMLP signalling was revealed,
uggesting that a compensatory mechanism is in operation
n S100A9 null neutrophils. However, a deficiency in Ca2+
ignalling has been detected in signalling via CC and CXC
hemokine and other receptors such as PAF and C5a. These
ndings indicate a situation where the basic Ca2+ release
athways used by both chemokine and the FMLP receptors
re similar, but the regulation of these pathways is different.
ur efforts have therefore also focussed on the chemokine-
ignalling pathway, which has been less well investigated.
he MIP-2 response in S100A9 null neutrophils was partic-
larly sensitive to increased DAG levels showing markedly
educed Ca2+ flux when exposed to DAG mimetic, OAG, and
he DAG kinase inhibitor, which prevents DAG hydrolysis.
s wildtype neutrophils only showed sensitivity at lower lev-
ls of chemokine (data not shown), a similar pathway to Ca2+
elease is triggered in wildtype and S100A9 null neutrophils,
ut there is a shift in sensitivity to increased DAG levels in
he latter cells. PKC is the best-identified downstream effec-
or of DAG but blocking PKC activity in several ways had no
mpact on the chemokine response. A recent publication has
ighlighted a modulatory role for DAG in IP3-generated Ca2+
scillations [55]. The findings differ from this present study
n that DAG has a positive rather than a negative effect on the
a2+ response and this effect is enhanced by inhibiting DAG
ipase activity, again in contrast to the situation in murine
eutrophils. However here also PKC appears not to have a
ole. Other downstream effectors are DAG are being identi-
ed [56,57] and further effort will be needed to dissect what
ppears to be a novel regulatory role for DAG downstream
f PLC activation.
Chemoattractants have been most thoroughly investigated
n terms of their ability to drive the chemotaxis of cells such as
eutrophils. Nevertheless we show that the ability to migrate
nd increase cell surface integrin expression in response to
hemoattractants is intact in S100A9 null neutrophils, in spite
f their compromised ability to flux Ca2+. Further insight
nto other roles of chemoattractants such as the chemokines
re required to define the function of the Ca2+ flux in which
100A8/9 participates. However, in terms of chemoattractant
ignalling, this study has revealed an unexpected involvement
100A8/9 at the level of PLC in the generation of Ca2+
elease by the IP3 receptor. Also highlighted is a strong mod-
latory role for DAG downstream of PLC particularly when
he pathway is triggered by chemokine.
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